FUGE-Funksjonell genomforskn.i Norg
Structure based rules for protein kinase inhibitor selectivity
Protein kinase inhibitors are now emerging as a major class of new targeted drugs. Many diseases, especially cancers, are associated with disregulation of signalling pathways, and modulation of protein kinase activity is now a clearly validated approach f or therapy. Because there are over 500 pr...
